Last reviewed · How we verify
3.5% ophthalmic lidocaine gel — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
3.5% ophthalmic lidocaine gel (3.5% ophthalmic lidocaine gel) — Miami VA Healthcare System.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| 3.5% ophthalmic lidocaine gel TARGET | 3.5% ophthalmic lidocaine gel | Miami VA Healthcare System | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- 3.5% ophthalmic lidocaine gel CI watch — RSS
- 3.5% ophthalmic lidocaine gel CI watch — Atom
- 3.5% ophthalmic lidocaine gel CI watch — JSON
- 3.5% ophthalmic lidocaine gel alone — RSS
Cite this brief
Drug Landscape (2026). 3.5% ophthalmic lidocaine gel — Competitive Intelligence Brief. https://druglandscape.com/ci/3-5-ophthalmic-lidocaine-gel. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab